Background: Nanomedicine is a field of science that uses nanoscale materials for the
diagnosis and treatment of human disease. It has emerged as an important aspect of the …

Acute kidney injury (AKI) is a clinical syndrome that complicates the course and worsens the
outcome in a significant number of hospitalised patients. Recent advances in clinical and …

Background Contrast-associated acute kidney injury can occur after percutaneous coronary
intervention (PCI). Prediction of the contrast-associated acute kidney injury risk is important …

Hydroxyapatite nanoparticles (HAP NPs) are host materials and can be modified with
various substrates and dopants. Among them, rare earth (RE) ions doped HAP NPs have …

Executive summary Acute kidney injury (AKI) is a major contributor to poor patient outcomes.
AKI occurs in about 13· 3 million people per year, 85% of whom live in the developing world …

Background The administration of intravenous fluid remains the cornerstone treatment for
the prevention of contrast-induced acute kidney injury. However, no well-defined protocols …

Contrast-induced nephropathy (CIN), also known as contrast-induced acute kidney injury, is
an iatrogenic renal injury that follows intravascular administration of radio-opaque contrast …

Contrast-induced nephropathy (CIN) is a frequent cause of acute kidney injury in
hospitalized patients. CIN is most commonly defined as either an absolute (≥ 0.5 mg/dL;≥ …

Background In this study, we tested the hypothesis that a combined adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat …

Iodinated contrast media (ICM) induced acute kidney injury (AKI) accounts for 11% of cases
of AKI and is its third most common cause in hospitalized patients. However, the …